CHRISTINE WATSON: Open Payments
NPI 1013943760 · WOODSTOCK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 34 payments from 11 companies in 2025. Trend: 2023 $356 · 2024 $970 · 2025 $768
Food & beverage: $583Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $196 |
| Amgen Inc. | 11 | $154 |
| Incyte Corporation | 3 | $82 |
| Lilly USA, LLC | 4 | $79 |
| ABBVIE INC. | 4 | $78 |
| Galderma Laboratories, L.P. | 2 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| UCB, Inc. | 2 | $30 |
| GENZYME CORPORATION | 1 | $18 |
| PFIZER INC. | 1 | $14 |
Products named: TREMFYA, OTEZLA, OPZELURA, EBGLYSS, SKYRIZI, NEMLUVIO, Bimzelx, Rhapsido.
Industry payments across IL — which companies pay providers there.
